Estuary Capital Management LP Day One Biopharmaceuticals, Inc. Transaction History
Estuary Capital Management LP
- $342 Billion
- Q4 2024
A detailed history of Estuary Capital Management LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Estuary Capital Management LP holds 3,716,777 shares of DAWN stock, worth $36.1 Million. This represents 13.76% of its overall portfolio holdings.
Number of Shares
3,716,777
Previous 2,743,780
35.46%
Holding current value
$36.1 Million
Previous $38.2 Billion
23.21%
% of portfolio
13.76%
Previous 10.25%
Shares
5 transactions
Others Institutions Holding DAWN
# of Institutions
176Shares Held
77.8MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$62.4 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$56.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$55.8 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$47.3 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$44 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $713M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...